Evidence map›Paper›PMID 39043661›Full record

ArticleNature communications2024

Single-nucleus RNA sequencing reveals glial cell type-specific responses to ischemic stroke in male rodents.

Daniel Bormann, Michael Knoflach, Emilia Poreba, Christian J Riedl, Giulia Testa, Cyrille Orset, Anthony Levilly, Andréa Cottereau, Philipp Jauk, Simon Hametner and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Single-cell RNA sequencing in stroke and traumatic brain injury: Current achievements, challenges and future perspectives on transcriptomic profiling.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Daniel BormannApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Michael KnoflachDepartment of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Emilia PorebaDepartment of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
Christian J RiedlDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Giulia TestaDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Cyrille OrsetNormandie University, UNICAEN, ESR3P, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie (BB@C), GIP Cyceron, Caen, France.
Anthony LevillyNormandie University, UNICAEN, ESR3P, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie (BB@C), GIP Cyceron, Caen, France.
Andréa CottereauNormandie University, UNICAEN, ESR3P, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Institut Blood and Brain @ Caen-Normandie (BB@C), GIP Cyceron, Caen, France.
Philipp JaukDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.ORCID 0009-0004-3504-8845
Simon HametnerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Nadine StranzlDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Bahar GolabiDepartment of Dermatology, Medical University of Vienna, 1090, Vienna, Austria.
Dragan CopicApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.ORCID 0000-0002-1005-2985
Katharina KlasApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Martin DirederApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Hannes KühtreiberApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Melanie SalekApplied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria.
Stephanie Zur NeddenInstitute of Neurobiochemistry, CCB-Biocenter, Medical University of Innsbruck, 6020, Innsbruck, Austria.
Gabriele Baier-BitterlichInstitute of Neurobiochemistry, CCB-Biocenter, Medical University of Innsbruck, 6020, Innsbruck, Austria.ORCID 0000-0002-7009-8168
Stefan KiechlDepartment of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Carmen HaiderDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Verena EndmayrDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.
Romana HöftbergerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, 1090, Vienna, Austria.ORCID 0000-0002-5769-1100
Hendrik J Ankersmit *Applied Immunology Laboratory, Department of Thoracic Surgery, Medical University of Vienna, 1090, Vienna, Austria. hendrik.ankersmit@meduniwien.ac.at.
Michael Mildner *Department of Dermatology, Medical University of Vienna, 1090, Vienna, Austria. michael.mildner@meduniwien.ac.at.ORCID 0000-0002-6892-925X

Funding

Deep Gray Matter Iron and Disease Progression in Multiple SclerosisR01NS114227 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SCHWESER, FERDINAND · 2021 to 2024
$1.5M
Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) #T109, #P31085-B26Austrian Science Fund FWF T 1091Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) #1R01NS114227-01A1NINDS NIH HHS R01 NS114227Österreichische Forschungsförderungsgesellschaft (Austrian Research Promotion Agency) #898252
6 · The paper itself

Abstract

Neuroglia critically shape the brain´s response to ischemic stroke. However, their phenotypic heterogeneity impedes a holistic understanding of the cellular composition of the early ischemic lesion. Here we present a single cell resolution transcriptomics dataset of the brain´s acute response to infarction. Oligodendrocyte lineage cells and astrocytes range among the most transcriptionally perturbed populations and exhibit infarction- and subtype-specific molecular signatures. Specifically, we find infarction restricted proliferating oligodendrocyte precursor cells (OPCs), mature oligodendrocytes and reactive astrocytes, exhibiting transcriptional commonalities in response to ischemic injury. OPCs and reactive astrocytes are involved in a shared immuno-glial cross talk with stroke-specific myeloid cells. Within the perilesional zone, osteopontin positive myeloid cells accumulate in close proximity to CD44

Indexed as

AstrocytesIschemic StrokeOligodendrocyte Precursor CellsOligodendrogliaSingle-Cell AnalysisAnimalsBrainBrain IschemiaCell MovementCell NucleusCell ProliferationDisease Models, AnimalMaleMiceMice, Inbred C57BLMyeloid CellsOsteopontinSpp1 protein, mouse

Identifiers

PMID39043661
PMCPMC11266704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.